CI · 10-Q · 2026Q3 · Full report

Liquidity and Cash Position

Cigna Group · 2026-11-05 · Importance 25 · Surprise 6

At September 30, 2026, Cigna had $6.5 billion of cash and short-term investments, including approximately $1.2 billion held by the parent company or certain non-regulated subsidiaries. It also had $6.5 billion of undrawn committed revolving-credit capacity and $6.0 billion of remaining commercial-paper capacity, against $0.5 billion of outstanding commercial paper. The debt-to-capitalization ratio declined to 41.8% from 43.0% at December 31, 2025. Dividends from U.S.-regulated subsidiaries totaled $1.0 billion in the first nine months of 2026, compared with $0.6 billion in the prior-year period.

Key facts

• At September 30, 2026, Cigna had $6.5 billion of undrawn revolving credit capacity, $6.0 billion of remaining commercial paper capacity, and $6.5 billion in cash and short-term investments, of which approximately $1.2 billion was held by the parent company or certain non-regulated subsidiaries. source
• Cigna cash flows used in investing activities were $2.414 billion in the first nine months of 2026, compared with $3.987 billion in 2025; lower investment purchases were partly offset by the absence of net proceeds from the HCSC transaction. source
• Dividends received by Cigna from U.S.-regulated subsidiaries were $1.0 billion in the first nine months of 2026, compared with $0.6 billion in the same period of 2025. source
• Cigna's parent company could borrow an additional $1.0 billion from subsidiaries without further approvals at September 30, 2026. source
• Cigna's commercial paper program had $0.5 billion outstanding at September 30, 2026. source
• Cigna's debt-to-capitalization ratio was 41.8% at September 30, 2026, compared with 43.0% at December 31, 2025. source
• Cigna net cash used in financing activities in 2026 was flat versus 2025, primarily because lower share repurchases were offset by net debt financing activities. source